张汝阳,南京医科大学流行病与卫生统计学博士、美国哈佛大学环境基因组学博士后、南京医科大学生物统计学系副教授、硕士生导师,入选江苏省高校“青蓝工程”优秀青年骨干教师培养对象、南京医科大学优秀中青年学科(学术)带头人培养对象。主要从事生物医学高维数据统计理论方法及临床应用研究,累计发表学术论文超百篇。其中,以第一、通讯作者身份发表一系列高质量论文:Journal of Thoracic Oncology (2022)、Molecular Cancer (2021)、Intensive Care Medicine (2015)、JAMA Network Open (2021)、EBioMedicine (2023/2022/2018)、NPJ Precision Oncology (2021)、Chest (2020)、Molecular Oncology (2022/2020封面论文/2019/2018)等。先后主持国家自然科学基金面上项目/青年项目、美国国家职业安全卫生研究所先导项目、江苏省自然科学基金等10项。曾获江苏医学科技奖二等奖、教育部高等学校科学研究优秀成果奖自然科学二等奖、首届人卫慕课在线开放课程建设比赛微课制作全国一等奖、全国高校微课教学比赛三等奖等。指导本科生获中国计算机设计大赛一/二等奖、江苏省普通高校本科优秀毕业论文三等奖、中国高校SAS数据分析大赛全国一/二等奖、MathorCup高校数学建模挑战赛二等奖等。
Ruyang Zhang, B.Med, PhD, is an Associate Professor of Epidemiology and Biostatistics in Nanjing Medical University (Nanjing, China), and is the elected member of the Outstanding Young Backbone Teacher of Qing Lan Project of Jiangsu Province and the Outstanding Young Level Academic Leadership Training Program of Nanjing Medical University. He achieved B.Med of Preventive Medicine (Biostatistics) and PhD of Epidemiology and Biostatistics at School of Public Health, Nanjing Medical University (Mentor: Professor Feng Chen) and finished two-year postdoctoral research works of genetic oncology at School of Public Health, Harvard University (Advisor: Professor David C. Christiani). Dr. Zhang’s major research interests primarily lie in the gene-gene, gene-environment and environment-environment interaction study of risk and prognosis of complex diseases of respiratory system (e.g., lung cancer and ARDS), risk and prognostic prediction model construction of complex diseases, and methodology of clinical trials. Funded by National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Harvard-NIOSH Education and Research Center Pilot Study, Natural Science Foundation of the Jiangsu Higher Education Institutions of China, etc., he published a series of SCI-indexed papers as first and corresponding authors, including Journal of Thoracic Oncology (2022), Molecular Cancer (2021), Intensive Care Medicine (2015), JAMA Network Open (2021), EBioMedicine (2023/2022/2018), NPJ Precision Oncology (2021), Chest (2020), Molecular Oncology (2022/2020 Cover Paper/2019/2018), Clinical Epigenetics (2018), etc. Dr. Zhang was awarded the Second Prize of Outstanding Scientific Research Achievement Award of Ministry of Education of China (2019) and Second Prize of Medical Science and Technology of Jiangsu Province (2020).
详见个人网页:http://gwxy.njmu.edu.cn/2017/0718/c8948a98532/page.htm